Llwytho...
VEGFA Genomic Amplification Tailors Treatment of HCCs with Sorafenib
In this issue of Cancer Discovery, Horwitz and colleagues identified a subtype of HCC bearing VEGFA genomic amplification that is particularly sensitive to VEGFA inhibition and also more sensitive to sorafenib treatment. Taken conjointly, these data suggest that VEGFA genomic amplification can be us...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cancer Discov |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633301/ https://ncbi.nlm.nih.gov/pubmed/24891362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-14-0406 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|